News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
632,408 Results
Type
Article (60715)
Company Profile (78)
Press Release (571615)
Section
Business (173437)
Career Advice (2710)
Deals (32375)
Drug Delivery (87)
Drug Development (76697)
Employer Resources (148)
FDA (14847)
Job Trends (13836)
News (304377)
Policy (28864)
Tag
Academia (2869)
Alliances (42817)
Alzheimer's disease (1171)
Approvals (14789)
Artificial intelligence (132)
Bankruptcy (281)
Best Places to Work (10753)
Breast cancer (117)
Cancer (1052)
Cardiovascular disease (90)
Career advice (2292)
Cell therapy (235)
Clinical research (60848)
Collaboration (370)
Compensation (116)
COVID-19 (2514)
C-suite (105)
Cystic fibrosis (82)
Data (1097)
Diabetes (137)
Diagnostics (5929)
Earnings (58536)
Employer resources (131)
Events (91832)
Executive appointments (321)
FDA (15377)
Funding (337)
Gene therapy (173)
GLP-1 (545)
Government (4381)
Healthcare (18079)
Infectious disease (2590)
Inflammatory bowel disease (106)
Interviews (521)
IPO (14593)
Job creations (3411)
Job search strategy (1935)
Layoffs (440)
Legal (6381)
Lung cancer (162)
Manufacturing (161)
Medical device (12472)
Medtech (12477)
Mergers & acquisitions (17899)
Metabolic disorders (365)
Neuroscience (1430)
NextGen Class of 2024 (6358)
Non-profit (4300)
Northern California (1321)
Obesity (202)
Opinion (204)
Patents (101)
People (58487)
Phase I (19087)
Phase II (26882)
Phase III (19601)
Pipeline (436)
Postmarket research (2465)
Preclinical (8144)
Radiopharmaceuticals (240)
Rare diseases (212)
Real estate (5971)
Regulatory (19350)
Research institute (2384)
Resumes & cover letters (404)
Southern California (1178)
Startups (3329)
United States (12098)
Vaccines (530)
Weight loss (146)
Date
Today (128)
Last 7 days (727)
Last 30 days (3537)
Last 365 days (32557)
2024 (29798)
2023 (36349)
2022 (46636)
2021 (51600)
2020 (50754)
2019 (44782)
2018 (34082)
2017 (30741)
2016 (30083)
2015 (35459)
2014 (28393)
2013 (24991)
2012 (26249)
2011 (26487)
2010 (24949)
Location
Africa (865)
Arizona (137)
Asia (37509)
Australia (7184)
California (2932)
Canada (1159)
China (226)
Colorado (137)
Connecticut (140)
Europe (86788)
Florida (422)
Georgia (113)
Illinois (349)
Indiana (172)
Kansas (87)
Maryland (530)
Massachusetts (2187)
Michigan (158)
Minnesota (225)
New Jersey (887)
New York (861)
North Carolina (707)
Northern California (1321)
Ohio (130)
Pennsylvania (746)
South America (1171)
Southern California (1178)
Texas (425)
Utah (87)
Washington State (322)
632,408 Results for "university of sydney".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CARTHERICS ENTERS AGREEMENTS WITH UNIQUEST, THE UNIVERSITY OF QUEENSLAND AND THE UNIVERSITY OF SYDNEY FOR ADVANCING INNOVATIVE CARDIAC CELLULAR THERAPY
July 25, 2024
·
4 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
PharmAla Biotech Receives Export Permit to Ship GMP LaNeo MDMA to the University of SydneyExport of LaNeo MDMA Completes August 2022 Contract Fulfillment
PharmAla Biotech Holdings Inc. is pleased to announce the receipt of an export permit for the shipment of its allotment of GMP LaNeo MDMA to the University of Sydney.
June 16, 2023
·
8 min read
BioMidwest
University of Cincinnati Cancer Center Launches Nation’s Most Comprehensive Blood Cancer Healing Center
The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.
June 24, 2024
·
4 min read
BCAL DIAGNOSTICS OPENS NEW LABORATORY IN SYDNEY AS IT ACCELERATES DEVELOPMENT OF ITS BREAST CANCER BLOOD SCREENING TOOL
BCAL Diagnostics Limited (ASX:BDX) (BCAL or Company) an Australian-based biotechnology company announced the opening of its development and clinical service laboratory in Sydney.
May 4, 2023
·
3 min read
Drug Development
ABVC BioPharma Vitargus® Phase II Study Received Ethical Approval at Sydney Eye Hospital in Australia
ABVC BioPharma, Inc. today announced that the Vitrargus® Phase II study at the Sydney Eye Hospital in New South Wales, Australia received ethical approval from the St. Vincent’s Hospital Melbourne Human Research Ethics Committee (HREC) on May 15, 2023.
May 22, 2023
·
3 min read
Rosalind Franklin University Helix 51 Biomedical Incubator Marks Fifth Anniversary, Rapid Expansion
NORTH CHICAGO, ILLINOIS, May 15, 2024 — Rosalind Franklin University’s Helix 51 biomedical incubator, the only one of its kind in Lake County, Illinois, celebrated its fifth year of...
May 15, 2024
·
2 min read
Bio NC
Pfizer invests $4.9M in McMaster University study to help improve care for multiple myeloma patients in Canada
Pfizer is proud to announce that it is supporting a McMaster University-led study, through the Ontario Clinical Oncology Group, that aims to improve care for Canadians living with multiple myeloma.
June 3, 2024
·
5 min read
PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney
PharmAla Biotech Holdings Inc., a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules, is thrilled that – following pre-submission meetings held in Q1 of 2023 – it has received written guidance from the UK’s Medicines and Healthcare products Regulatory Agency’s.
July 20, 2023
·
8 min read
1 of 63,241
Next
